Breast neoplasm
- Synonyms
- Breast Neoplasms; Breast tumor; Neoplasm of breast; Neoplasm of the breast
Summary
Available tests
Check Related conditions for additional relevant tests.
- NICE, 2024UK NICE Guideline NG101, Early and locally advanced breast cancer: diagnosis and management, 2024
- NCCN, 2023Breast Cancer, NCCN Guidelines Version 4.2022
- NCCN, 2022Breast Cancer Screening and Diagnosis, NCCN, Version 1.2022
- NICE, 2018Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer (DG34)
- NICE, 2018Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer, NICE, 2018
- NCCN, 2014National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology. Breast Cancer (See 2022 Update)
- NICE, 2013DG10 Gene expression profiling and expanded immunohistochemistry tests for guiding adjuvant chemotherapy decisions in early breast cancer management: MammaPrint, Oncotype DX, IHC4 and Mammostrat: information for the public
- AHRQ, 2013Technology Assessment on Genetic Testing or Molecular Pathology Testing of Cancers with Unknown Primary Site to Determine Origin (ARCHIVED)
- NCCN, 2011NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology.
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.